Hugel, Inc. (145020)の価格はいくらですか

Hugel, Inc. (145020)の価格は$170.80です

Hugel, Inc. (145020)の時価総額は何ですか

Hugel, Inc. (145020)の時価総額は$1.85Bです

Hugel, Inc.（145020）の株価履歴

Hugel, Inc. is a biopharmaceutical firm headquartered in Chuncheon-si, South Korea, with a presence both domestically and internationally. The company specializes in the development and manufacturing of diverse medical solutions. A primary product is its Botulinum Toxin, presented as a clear glass vial containing a white, injectable dry powder. This therapeutic is prescribed for several conditions: treating essential eyelid spasms in adults over 18; ameliorating severe frown lines linked to corrugator and/or procerus muscle activity in adults aged 18 to 65; managing upper limb spasticity following a stroke; and correcting dynamic equinus foot deformity in children with cerebral palsy aged over 2. Furthermore, it aids in improving the lateral canthal lines (crow's feet) caused by orbicularis oculi muscle activity in adults between 19 and 65. This product is marketed under various labels, including Botulax, Regenox, Zentox, Reage, Magnion, Hugel Toxin, Juvenlife, Botulim, and Botoshot. Hugel also provides hyaluronic acid dermal fillers, known as Dermalax and The Chaeum; cosmetic products under the Wellage brand; and medical devices distributed as BlueRose. Hugel, Inc. commenced operations in 2001.

年	パフォーマンス
2026 (TTM)	14.00%
2025	-16.79%
2024	62.92%
2023	14.44%
2022	-21.30%
2021	-24.64%
2020	58.14%
2019	2.42%
2018	-31.10%
2017	76.88%
2016	66.79%
2015	0.00%

年

パフォーマンス

2026 (TTM)

14.00%

2025

-16.79%

2024

62.92%

2023

14.44%

2022

-21.30%

2021

-24.64%

2020

58.14%

2019

2.42%

2018

-31.10%

2017

76.88%

2016

66.79%

2015

0.00%

企業	株価	変化率 1年%	国
Vertex Pharmaceuticals Incorporated VRTX.US	$548.36	39.87%	US
Argenx SE ARGX.US	$1.06K	50.29%	NL
CSL Limited CSL.AX	$121.22	-12.71%	AU
Moderna, Inc. MRNA.US	$140.81	475.44%	US
Lonza Group AG LONN.SW	$765.25	7.74%	CH

企業

株価

変化率 1年%

国